MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway

被引:64
|
作者
Zhao, Wen [2 ]
Sun, Qiang [4 ]
Yu, Zepeng [1 ]
Mao, Shuai [5 ]
Jin, Yingkang [2 ]
Li, Jiajun [1 ]
Jiang, Zhiyi [1 ]
Zhang, Yongqiang [1 ]
Chen, Mian [1 ]
Chen, Peiran [1 ]
Chen, Dongdong [1 ]
Xu, Hailin [1 ]
Ding, Shangwei [3 ]
Yu, Zhiqi [1 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 2, Dept Resp Med, Guangzhou 510260, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Affiliated Hosp 1, Dept Resp Med, Guangzhou 510120, Guangdong, Peoples R China
[3] Southern Med Univ, Dongguan Peoples Hosp, Dept Ultrasonog, Dongguan 523059, Guangdong, Peoples R China
[4] Zhongshan Sch Med, Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Guangzhou 510080, Guangdong, Peoples R China
[5] Guangdong Prov Hosp Chinese Med, Dept Crit Care Med, Guangzhou 510120, Guangdong, Peoples R China
关键词
miR-320a-3p; ELF3; PI3K/Akt; NSCLC; ELF3; MESSENGER-RNA; TRANSCRIPTION FACTOR; LIVER METASTASIS; ESE-1;
D O I
10.1016/j.gene.2018.05.100
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
MicroRNAs (miRNAs) play important roles in tumorigenesis and tumor progression. In this study, we investigated the role of miR-320a-3p in non-small cell lung cancer (NSCLC). Expressions of miR-320a-3p were firstly determined in 80 NSCLC patients' cancer tissues and adjacent normal lung tissues by qRT-PCR. Then MTT assay, cell migration and invasion assays were performed in vitro. Potential binding sites on target gene of miR320a-3p were predicted and luciferase reporter assay was used to identify the potential binding sites. Tumorigenesis assay were performed in nude mice by injecting A549 cells which stably express miR-320a-3p. Results indicated that high expression of miR-320a-3p suppresses cell proliferation, migration and invasion through the inactivation of PI3K/Akt signaling pathway in NSCLC cells. Smaller tumor size and lighter weight were also found in nude mice which had miR-320a-3p higher expressed. Furthermore, data from luciferase reporter assay proved the direct binding of miR-320a-3p on the 3'UTR region of ELF3 mRNA, this could further decrease ELF3 expression transcriptionally. We provided evidence that miR-320a-3p might work as a tumor suppressor in NSCLC both in vivo and in vitro.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 50 条
  • [41] Implications of different mechanisms of PI3K/AKT activation in non-small cell lung cancer
    Zou, Yong
    Rahman, S. M.
    Massion, Pierre P.
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [42] PP2A regulates metastasis and vasculogenic mimicry formation via PI3K/AKT/ZEB1 axis in non-small cell lung cancers
    Zhang, Yu
    Wang, Xingchen
    Li, Anqi
    Guan, Yanhui
    Shen, Peibo
    Ni, Yingqian
    Han, Xiuzhen
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2022, 150 (02) : 56 - 66
  • [43] PTEN and PI3K/AKT in non-small-cell lung cancer
    Perez-Ramirez, Cristina
    Canadas-Garre, Marisa
    Angel Molina, Miguel
    Jose Faus-Dader, Maria
    Angel Calleja-Hernandez, Miguel
    [J]. PHARMACOGENOMICS, 2015, 16 (16) : 1843 - 1862
  • [44] miR-196b regulates gastric cancer cell proliferation and invasion via PI3K/AKT/mTOR signaling pathway
    Li, Na
    Wang, Weiqiang
    Xu, Bin
    Gong, Hongyun
    [J]. ONCOLOGY LETTERS, 2016, 11 (03) : 1745 - 1749
  • [45] PI3K/AKT inhibition induces compensatory activation of the MET/STAT3 pathway in non-small cell lung cancer
    Bian, Chunan
    Liu, Zonghang
    Li, Dakou
    Zhen, Lifeng
    [J]. ONCOLOGY LETTERS, 2018, 15 (06) : 9655 - 9662
  • [46] PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway
    Wang, Shu
    Cheng, Zhiming
    Cui, Yan
    Xu, Shuoyan
    Luan, Qiu
    Jing, Shan
    Du, Bulin
    Li, Xuena
    Li, Yaming
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [47] UBR5 inhibits the radiosensitivity of non-small cell lung cancer cells via the activation of the PI3K/AKT pathway
    Gu, Yong-Fei
    Ge, Xing-Ping
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (05) : 970 - 975
  • [48] PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway
    Shu Wang
    Zhiming Cheng
    Yan Cui
    Shuoyan Xu
    Qiu Luan
    Shan Jing
    Bulin Du
    Xuena Li
    Yaming Li
    [J]. Journal of Translational Medicine, 21
  • [49] Small Molecule Demonstrates Potent Tumor Suppression by Inhibiting the PI3K/AKT Pathway in Non-Small Cell Lung Cancer
    Woodard, Gavitt A.
    Crockard, Jane
    Peto, Csaba
    Tolani, Bhairavi
    He, Biao
    Jablons, David
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S314 - S314
  • [50] miR-496 suppress tumorigenesis via targeting BDNF-mediated PI3K/Akt signaling pathway in non-small cell lung cancer
    Ma, Rui
    Zhu, Pan
    Liu, Shu
    Gao, Baoqin
    Wang, Wei
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 518 (02) : 273 - 277